Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Medicine|February 27, 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinomaTomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2026
Long-Term Oncologic Outcomes After Laparoscopic Radical Nephroureterectomy: A Contemporary Analysis From a Japanese Multicenter CohortToru Kanno, Ryoichi Saito, Yuki Kita, et al.
Cancer Science|November 3, 2023
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamideTakashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, et al.
Annals of Surgical Oncology|April 6, 2026
Stage-Specific Prognostic Impact of Tumor Location in Upper Tract Urothelial Carcinoma: A Propensity Score-Matched AnalysisShigeki Koterazawa, Toru Kanno, Yuki Kita, et al.
The Prostate|May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate CancerTakuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
Cancer Genetics|June 12, 2022
A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndromeTakeshi Sano, Tomohiro Fukui, Noriyuki Makita, et al.
Cancer Science|May 7, 2021
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13Kosuke Okasho, Kei Mizuno, Tomohiro Fukui, et al.
Human Molecular Genetics|June 28, 2022
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controlsYuya Sekine, Yusuke Iwasaki, Tomomi Aoi, et al.
World Journal of Urology|June 2, 2026
Applying classification of intraoperative adverse events (ClassIntra) to robot-assisted radical prostatectomy to predict the risk of postoperative adverse eventsShinya Somiya, Ryoichi Saito, Toru Kanno, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2021
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLRTakashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, et al.
Pageof 4